ALX Oncology Holdings Inc. fell 13.6% on Tuesday, November 10, 2026, on 529,300 shares. The headline around the move:
ALX Oncology Holdings Inc. (ALXO:NASDAQ) closed at $1.01 on November 17, 2026, up 1.00% on the day. The stock trades 62.0% below its 52-week high of $2.66 and 17.2% above its 52-week low of $0.862. Over the past year, it lost 35.9%. ALX Oncology Holdings Inc. is part of the Health Care sector.
In 252 trading sessions since November 14, 2025, ALXO closed higher on 112 days (44%). Its best day was January 29, 2026 (+14.60%) and its worst was October 13, 2026 (-22.22%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 1 time.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company. The firm is focused on developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. Its lead product candidate under development, ALX148, is a next-generation CD47 blocking therapeutic for the treatment of first-line head and neck cancer and second-line gastric/gastroesophageal junction cancer and breast cancer.
Find more stocks like ALXO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.